Dutch researchers are proposing that donated cord blood to be used for transplants be matched to recipients according to noninherited maternal antigens instead of human leukocyte antigens. In their study, patients transplanted with NIMA-matched cord blood were 40% less likely than those who didn't have any kind of match to have died three years following the procedure. Patients who had HLA-matched cord blood transplants were 60% less likely to have died compared with those who didn't have either kind of match. The researchers also said NIMA-matched cord blood engrafted faster and had lower incidence of graft-versus-host disease.
Published in Brief: